Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Vento

Showing results (71-80 of 169) with videos related to

Pageof 17
Sort By:
AIDS Research and Human Retroviruses|December 25, 2010
Antiretroviral therapy-associated diseases are common in the long-termMassimiliano Lanzafame, Emanuela Lattuada, Giacomo Zoppini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 14, 2013
A maintenance dose of atazanavir/ritonavir 200/100 mg once daily is effective in virologically suppressed HIV-1-infected patientsMassimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2015
Liver diseases in sub-Saharan Africa: the importance of dedicated public clinicsFrancesca Cainelli, Malebogo Ralethaka, Thato Kaang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 30, 2012
Isoniazid preventive therapy in human immunodeficiency virus infectionLorenzo Guglielmetti, Emanuela Lattuada, Massimiliano Lanzafame, et al.
The Lancet. Global Health|March 15, 2017
Cerebral palsy: a multidisciplinary, integrated approach is essentialSholpan Bulekbayeva, Zholtay Daribayev, Sholpan Ospanova, et al.
AIDS Patient Care and Stds|May 25, 2013
Efficacy of a reduced dose of darunavir/ritonavir in a small cohort of antiretroviral-naïve HIV-infected patientsMassimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 12, 2013
Comparative chromatography-mass spectrometry studies on the antiretroviral drug nevirapine-analytical performance characteristics in human plasma determinationKwenga Sichilongo, Mompati Chinyama, Amos Massele, et al.
Frontiers in Medicine|March 3, 2020
Alcohol? Not for Non-alcoholic Fatty Liver Disease PatientsFrancesca Cainelli, Titya Thao, Carolyne Pung, et al.
The Lancet. Global Health|September 17, 2018
Liver cirrhosis in sub-Saharan Africa: neglected, yet importantSandro Vento, Bartholomew Dzudzor, Francesca Cainelli, et al.
Journal of Medical Virology|April 22, 2022
Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections?Massimiliano Lanzafame, Enrico Gibbin, Emanuela Lattuada, et al.
Pageof 17

Showing results (71-80 of 169) with videos related to

Sort By:
Pageof 17
AIDS Research and Human Retroviruses|December 25, 2010
Antiretroviral therapy-associated diseases are common in the long-termMassimiliano Lanzafame, Emanuela Lattuada, Giacomo Zoppini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 14, 2013
A maintenance dose of atazanavir/ritonavir 200/100 mg once daily is effective in virologically suppressed HIV-1-infected patientsMassimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2015
Liver diseases in sub-Saharan Africa: the importance of dedicated public clinicsFrancesca Cainelli, Malebogo Ralethaka, Thato Kaang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 30, 2012
Isoniazid preventive therapy in human immunodeficiency virus infectionLorenzo Guglielmetti, Emanuela Lattuada, Massimiliano Lanzafame, et al.
The Lancet. Global Health|March 15, 2017
Cerebral palsy: a multidisciplinary, integrated approach is essentialSholpan Bulekbayeva, Zholtay Daribayev, Sholpan Ospanova, et al.
AIDS Patient Care and Stds|May 25, 2013
Efficacy of a reduced dose of darunavir/ritonavir in a small cohort of antiretroviral-naïve HIV-infected patientsMassimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 12, 2013
Comparative chromatography-mass spectrometry studies on the antiretroviral drug nevirapine-analytical performance characteristics in human plasma determinationKwenga Sichilongo, Mompati Chinyama, Amos Massele, et al.
Frontiers in Medicine|March 3, 2020
Alcohol? Not for Non-alcoholic Fatty Liver Disease PatientsFrancesca Cainelli, Titya Thao, Carolyne Pung, et al.
The Lancet. Global Health|September 17, 2018
Liver cirrhosis in sub-Saharan Africa: neglected, yet importantSandro Vento, Bartholomew Dzudzor, Francesca Cainelli, et al.
Journal of Medical Virology|April 22, 2022
Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections?Massimiliano Lanzafame, Enrico Gibbin, Emanuela Lattuada, et al.
Pageof 17